4 Results for "

CDK9-IN-1 (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CDK9-IN-1 (Standard)" in MCE Product Catalog:

Cat. No.: HY-13231R
CAS No.: 1415559-43-1
Target:  

CDK HIV

Research Areas:  

Infection

CDK9-IN-1 (Standard) is the analytical standard of CDK9-IN-1. This product is intended for research and analytical applications. CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.
loading...
    loading...
Cat. No.: HY-103628R
CAS No.: 2118356-96-8
Research Areas:  

Cancer

PROTAC CDK9 Degrader-1 (Standard) is the analytical standard of PROTAC CDK9 Degrader-1 (HY-103628). This product is intended for research and analytical applications. PROTAC CDK9 Degrader-1 is a PROTAC connected by ligands for Cereblon and CDK as a selective CDK9 degrader.
loading...
    loading...
Cat. No.: HY-10492R
CAS No.: 779353-01-4
Synonyms: SCH 727965 (Standard)
Research Areas:  

Cancer

Dinaciclib (Standard) is the analytical standard of Dinaciclib (HY-10492). This product is intended for research and analytical applications. Dinaciclib (SCH 727965) is a potent inhibitor of CDK, with IC50s of 1 nM, 1 nM, 3 nM, and 4 nM for CDK2, CDK5, CDK1, and CDK9, respectively .
loading...
    loading...
Cat. No.: HY-101212R
CAS No.: 1070790-89-4
Synonyms: CYC065 (Standard)
Target:  

CDK Reference Standards

Research Areas:  

Cancer

Fadraciclib (Standard) is the analytical standard of Fadraciclib (HY-101212). This product is intended for research and analytical applications. Fadraciclib (CYC065) is a second-generation, orally available ATP-competitive inhibitor of CDK2/CDK9 kinases with IC50s of 5 and 26 nM, respectively .
loading...
    loading...